Log in

NASDAQ:MBRXMoleculin Biotech News Headlines

$1.07
0.00 (0.00 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.07
Now: $1.07
$1.07
50-Day Range
$0.56
MA: $1.10
$1.47
52-Week Range
$0.32
Now: $1.07
$1.97
VolumeN/A
Average Volume302,183 shs
Market Capitalization$64.63 million
P/E RatioN/A
Dividend YieldN/A
Beta2.44

Headlines

Moleculin Biotech (NASDAQ MBRX) News Headlines

Source:
DateHeadline
Moleculin Provides Update on Coronavirus Drug DevelopmentMoleculin Provides Update on Coronavirus Drug Development
www.prnewswire.com - May 27 at 6:42 PM
Moleculin Announces Common Stock Will Resume Trading on the NASDAQ on May 28, 2020Moleculin Announces Common Stock Will Resume Trading on the NASDAQ on May 28, 2020
finance.yahoo.com - May 27 at 6:42 PM
-$0.10 EPS Expected for Moleculin Biotech Inc (NASDAQ:MBRX) This Quarter-$0.10 EPS Expected for Moleculin Biotech Inc (NASDAQ:MBRX) This Quarter
www.americanbankingnews.com - May 26 at 8:21 PM
Moleculin Announces Nasdaq Trading Halt Pending Receipt of Additional InformationMoleculin Announces Nasdaq Trading Halt Pending Receipt of Additional Information
finance.yahoo.com - May 18 at 8:19 AM
UPDATE: Moleculin Biotech, CNS Pharma     shares remain halted on NasdaqUPDATE: Moleculin Biotech, CNS Pharma shares remain halted on Nasdaq
finance.yahoo.com - May 18 at 8:19 AM
Moleculin Biotech did not solicit claims third parties made about a COVID-19 drug candidate that led to an SEC haltMoleculin Biotech did not solicit claims third parties made about a COVID-19 drug candidate that led to an SEC halt
www.msn.com - May 12 at 6:32 PM
Moleculin Provides Additional Comments Regarding Trading HaltMoleculin Provides Additional Comments Regarding Trading Halt
finance.yahoo.com - May 11 at 9:08 AM
UPDATE: Moleculin Biotech and CNS Pharma comment on SEC trading haltUPDATE: Moleculin Biotech and CNS Pharma comment on SEC trading halt
finance.yahoo.com - May 11 at 9:08 AM
Moleculin Announces Intention to Adjourn 2020 Annual Meeting of Stockholders to June 15, 2020Moleculin Announces Intention to Adjourn 2020 Annual Meeting of Stockholders to June 15, 2020
finance.yahoo.com - May 8 at 5:59 PM
Investor Alert: Kaplan Fox Investigates Moleculin Biotech, Inc.Investor Alert: Kaplan Fox Investigates Moleculin Biotech, Inc.
finance.yahoo.com - May 8 at 5:59 PM
SEC Puts the Kibosh on 3 Biotech Stocks Hawking a Miracle Anti-Coronavirus DrugSEC Puts the Kibosh on 3 Biotech Stocks Hawking a Miracle Anti-Coronavirus Drug
finance.yahoo.com - May 6 at 1:49 PM
SEC takes action against three more companies over COVID-19 claimsSEC takes action against three more companies over COVID-19 claims
finance.yahoo.com - May 4 at 5:06 PM
Moleculin Biotech Inc (NASDAQ:MBRX) Expected to Announce Earnings of -$0.10 Per ShareMoleculin Biotech Inc (NASDAQ:MBRX) Expected to Announce Earnings of -$0.10 Per Share
www.americanbankingnews.com - May 3 at 11:20 PM
Moleculin to Speak on COVID-19 Panel at Maxim Group's Infectious Disease Virtual ConferenceMoleculin to Speak on COVID-19 Panel at Maxim Group's Infectious Disease Virtual Conference
finance.yahoo.com - April 29 at 9:34 AM
WPD Pharmaceutical’s Annamycin Drug Approved for Accelerated European Clinical TrialWPD Pharmaceutical’s Annamycin Drug Approved for Accelerated European Clinical Trial
finance.yahoo.com - April 29 at 4:33 AM
Moleculin Approved to Accelerate European Clinical TrialMoleculin Approved to Accelerate European Clinical Trial
finance.yahoo.com - April 28 at 8:31 AM
Moleculin Biotech, Inc. (MBRX) Flat As Market Gains: What You Should KnowMoleculin Biotech, Inc. (MBRX) Flat As Market Gains: What You Should Know
finance.yahoo.com - April 27 at 10:30 PM
Is Moleculin Biotech (MBRX) Stock Outpacing Its Medical Peers This Year?Is Moleculin Biotech (MBRX) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - April 27 at 12:29 PM
WPD Pharmaceuticals’ Annamycin Drug Candidate Meets Endpoint in Successful U.S. Phase 1 AML Trial With No Evidence of CardiotoxicityWPD Pharmaceuticals’ Annamycin Drug Candidate Meets Endpoint in Successful U.S. Phase 1 AML Trial With No Evidence of Cardiotoxicity
finance.yahoo.com - April 23 at 8:09 AM
Moleculin Announces Head of NIAID Antiviral Drug Discovery and Development Center Joins COVID-19 Drug Development TeamMoleculin Announces Head of NIAID Antiviral Drug Discovery and Development Center Joins COVID-19 Drug Development Team
finance.yahoo.com - April 22 at 8:16 AM
WPD Pharmaceuticals and CNS Pharmaceuticals Announce Additional Coronavirus Testing on WP1122 by ImQuest BiosciencesWPD Pharmaceuticals and CNS Pharmaceuticals Announce Additional Coronavirus Testing on WP1122 by ImQuest Biosciences
finance.yahoo.com - April 21 at 7:13 AM
Moleculin Bio up 6% premarket on WP1122 deal for COVID-19Moleculin Bio up 6% premarket on WP1122 deal for COVID-19
seekingalpha.com - April 20 at 10:58 AM
Moleculin Announces Agreement with ImQuest Biosciences to Expand Coronavirus TestingMoleculin Announces Agreement with ImQuest Biosciences to Expand Coronavirus Testing
finance.yahoo.com - April 20 at 10:58 AM
Moleculin Announces Leading Virologist Joins Development TeamMoleculin Announces Leading Virologist Joins Development Team
finance.yahoo.com - April 15 at 9:22 AM
Moleculin (MBRX) Looks Good: Stock Adds 5.3% in SessionMoleculin (MBRX) Looks Good: Stock Adds 5.3% in Session
finance.yahoo.com - April 14 at 1:20 PM
Moleculin Biotech to hold investor call on April 16; shares up 12% premarketMoleculin Biotech to hold investor call on April 16; shares up 12% premarket
seekingalpha.com - April 14 at 8:20 AM
Moleculin Announces Investor Conference Call to Discuss COVID-19 Potential for Drug CandidateMoleculin Announces Investor Conference Call to Discuss COVID-19 Potential for Drug Candidate
finance.yahoo.com - April 14 at 8:20 AM
3 Biotech Stocks Under $2 With Massive Upside Potential3 Biotech Stocks Under $2 With Massive Upside Potential
finance.yahoo.com - April 12 at 7:41 AM
WPD Pharmaceuticals Clarifies News on Licensed Drug CandidateWPD Pharmaceuticals Clarifies News on Licensed Drug Candidate
www.benzinga.com - April 9 at 5:24 PM
Is Moleculin Biotech (MBRX) Outperforming Other Medical Stocks This Year?Is Moleculin Biotech (MBRX) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - April 9 at 12:23 PM
Why Moleculin Biotechs Stock Is Trading Higher TodayWhy Moleculin Biotech's Stock Is Trading Higher Today
www.benzinga.com - April 8 at 7:53 PM
Why Moleculin Biotechs Coronavirus Treatment Could Be HugeWhy Moleculin Biotech's Coronavirus Treatment Could Be Huge
247wallst.com - April 8 at 2:52 PM
Moleculin Biotech rockets 115% premarket on potential COVID-19 treatmentMoleculin Biotech rockets 115% premarket on potential COVID-19 treatment
seekingalpha.com - April 8 at 9:52 AM
Thinking about buying stock in Camber Energy, Cypress Semiconductor, Delta Air Lines, Moleculin Biotech, or TOP Ships?Thinking about buying stock in Camber Energy, Cypress Semiconductor, Delta Air Lines, Moleculin Biotech, or TOP Ships?
www.prnewswire.com - April 8 at 9:52 AM
Moleculin Biotech rockets on potential COVID-19 treatmentMoleculin Biotech rockets on potential COVID-19 treatment
seekingalpha.com - April 8 at 9:52 AM
Moleculin Announces Active Compound in WP1122 Reduces Coronavirus Replication In Vitro by 100%Moleculin Announces Active Compound in WP1122 Reduces Coronavirus Replication In Vitro by 100%
finance.yahoo.com - April 8 at 9:52 AM
Moleculin Biotech Doubles In Pre-Market Trading On Potential Covid-19 TreatmentMoleculin Biotech Doubles In Pre-Market Trading On Potential Covid-19 Treatment
finance.yahoo.com - April 8 at 9:52 AM
Moleculin Announces Additional Positive Safety Data in EU AML TrialMoleculin Announces Additional Positive Safety Data in EU AML Trial
finance.yahoo.com - April 2 at 5:31 PM
WPD Pharmaceuticals Partners with CNS Pharmaceuticals on Drug Development for Coronavirus and Other Antiviral IndicationsWPD Pharmaceuticals Partners with CNS Pharmaceuticals on Drug Development for Coronavirus and Other Antiviral Indications
finance.yahoo.com - March 24 at 8:06 AM
Moleculin to Present at the Life Sciences Investor ForumMoleculin to Present at the Life Sciences Investor Forum
finance.yahoo.com - March 24 at 8:06 AM
Moleculin Bio +15% premarket on filing new patent for Covid-19 drug candidateMoleculin Bio +15% premarket on filing new patent for Covid-19 drug candidate
seekingalpha.com - March 20 at 12:31 PM
Moleculin Announces Patent Filing to Cover New Coronavirus Drug CandidateMoleculin Announces Patent Filing to Cover New Coronavirus Drug Candidate
finance.yahoo.com - March 20 at 12:31 PM
The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation CompanyThe Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company
finance.yahoo.com - March 20 at 12:31 PM
Moleculin Biotech, Inc. Reports Financial Results for the Year Ended December 31, 2019Moleculin Biotech, Inc. Reports Financial Results for the Year Ended December 31, 2019
finance.yahoo.com - March 19 at 7:58 PM
WPD PHARMACEUTICALS’ WP1122 DRUG TO BE TESTED ON A RANGE OF VIRUSES INCLUDING CORONAVIRUSWPD PHARMACEUTICALS’ WP1122 DRUG TO BE TESTED ON A RANGE OF VIRUSES INCLUDING CORONAVIRUS
finance.yahoo.com - March 19 at 4:57 AM
18 Healthcare Stocks Moving In Tuesdays Pre-Market Session18 Healthcare Stocks Moving In Tuesday's Pre-Market Session
www.benzinga.com - March 17 at 3:05 PM
Moleculin Biotech up 48% on potential of candidates against coronavirusMoleculin Biotech up 48% on potential of candidates against coronavirus
seekingalpha.com - March 17 at 3:05 PM
Moleculin Signs Agreement with UTMB to Test WP1122 on a Range of Viruses, Including CoronavirusMoleculin Signs Agreement with UTMB to Test WP1122 on a Range of Viruses, Including Coronavirus
finance.yahoo.com - March 17 at 3:05 PM
Moleculin Announces Dr. Hongbo Zhai Joins Science Advisory BoardMoleculin Announces Dr. Hongbo Zhai Joins Science Advisory Board
finance.yahoo.com - March 10 at 12:33 PM
Moleculin Issues Video Shareholder LetterMoleculin Issues Video Shareholder Letter
finance.yahoo.com - March 4 at 10:57 AM
This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.